Real Clients. Real Results.

Devices Devices Reimbursement

Case Study: Reimbursement Strategy for Lifesaving Cervical Dilator

Reimbursement

Occupational Therapy, Valuation of New Assessment Codes

Reimbursement

Remote Therapeutic Monitoring

ADVI worked with the client and the AMA’s Digital Medicine Payment Advisory Committee to develop new CPT codes for remote therapeutic monitoring.

Reimbursement

Cardiovascular Technologies

Reviewed primary clinical study literature and, based on published Medicare precedents and processes, produced mock National Coverage Determinations on several invasive cardiovascular technologies, applying typical CMS standards and formats.

Reimbursement

Lumbar Spine Stenosis Device

ADVI worked with the client and CMS to reverse a negative draft NCD and obtained a final NCD with CED that required a randomized clinical study.

Reimbursement

Non-Opioid Device Pain Relief Product

Assessed the positioning of a client's non-opioid pain relief device versus competitive products, including drugs and other devices used to treat pain.

Reimbursement

AI Device for Osteoporosis Assessment

ADVI helped a client obtain a new Category I CPT code for the trabecular bone score AI software device.

Reimbursement

Osseochondral Knee Implant

ADVI analyzed the reimbursement environment for a novel osseochondral implant under development to determine whether existing codes and payment would be sufficient for the new device.

Reimbursement

Wound Product

Repositioned a struggling wound care device away from dressings and obtained a new CPT code allowing a physician or qualified healthcare professional to dispense the device as part of a professional service.

Reimbursement

Diabetic Devices and Supplies

Tracked historical CMS reimbursement changes for diabetic devices and supplies and evaluated the impact Medicare payment rates had on commercial pricing so the client was able to better understand and prepare internal forecasting for how newly proposed regulations may affect commercial plans rates in the future.

Reimbursement

Commercial Strategy for Orphan Disease Commercial Strategy

To support the pre-launch reimbursement planning for a global pharmaceutical client’s novel orphan drug with multiple uses – including maternal fetal – ADVI developed a payor plan, a reimbursement landscape, as well as a coding strategy

Reimbursement

Part A and Part B Drug Codes

Led countless manufacturers in the application submission for Part B HCPCS Coding and Pass-Through Status and supported manufacturers in advocacy efforts to ensure optimal code award.